CRISPR Therapeutics AG (NASDAQ:CRSP) is a pioneer in gene-editing technology, using its patented gene sequencing platform to ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

CRISPR Therapeutics AG (CRSP) closed at $43.42 in the latest trading session, marking a -1.83% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.29%. Meanwhile ...

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has earned a consensus recommendation of “Hold” from the nineteen brokerages that are covering the firm, Marketbeat Ratings reports.

CRISPR Therapeutics AG (CRSP) closed at $43.42 in the latest trading session, marking a -1.83% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.29%.

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options become available today, for the March 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Prominent blockchain researcher Chen Jing has left the United States to join Tsinghua University in Beijing as a full-time professor. The award-winning scholar and chief scientist said she would ...

The award celebrates the best mysteries across the fiction, nonfiction and television genres Penguin Random House-Riverhead Books/Amazon; Simon & Schuster-Atria Books/Amazon; Macmillan Publishers ...

The iHeartRadio Music Award nominations were announced Wednesday, and it was a good day for Taylor Swift and Morgan Wallen. The two artists each earned 10 nominations, followed by Kendrick Lamar ...